GALVESTON, Texas--(BUSINESS WIRE)--Chrysalis BioTherapeutics today announced it was selected to participate in the 2024 Respiratory Innovation Summit (RIS) at the American Thoracic Society Meeting in ...
GSK (NYSE:GSK) said on Tuesday that it will acquire clinical-stage biopharmaceutical company Aiolos Bio for a $1B upfront payment and up to $400M on achieving certain regulatory milestones. It will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results